CSI Market
Sign In | Register

Novartis Ag (NVS) Annual Balance Sheets

Annual · GAAP · USD millions
Access NVS quarterly Balance Sheets →
Looking at balance sheet data from Novartis Ag through Dec 31 2021 provides insight into Dec 31 2025's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash And Cash Equivalents11,435.00
Current Tax Assets Current205.00
Cash & Short-term Investments11,640.00
Accounts receivable8,937.00
Notes Receivable, Current6,269.00
Other Current Assets4,608.00
Total Current Assets30,460.00
Equipment/Property/Plant Net10,782.00
Goodwill net25,567.00
Intangible Assets29,411.00
Deferred Tax Assets5,438.00
Other Assets, Noncurrent38,702.00
Other Current Financial Assets155.00
Other Current Nonfinancial Assets3,459.00
Noncurrent Assets80,489.00
Investment Accounted For Using Equity Method98.00
Noncurrent Financial Assets2,348.00
Rightofuse Assets1,570.00
Total Assets110,949.00
Liabilities
Short-term Debt794.00
Other Liabilities, Current27,278.00
Total Current Liabilities27,278.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI3,397.00
Other liabilities, Noncurrent33,725.00
Trade And Other Payables To Trade Suppliers4,456.00
Other Current Financial Liabilities5,602.00
Current Tax Liabilities Current1,969.00
Other Current Nonfinancial Liabilities14,988.00
Total Liabilities64,400.00
Stockholders' Equity
Other Noncurrent Financial Liabilities27,935.00
Other Equity18,631.00
Common Stockholder's Equity46,566.00
Total Stockholder's Equity46,549.00
Liabilities & Stockholder's Equity110,949.00
4 historic quarters locked

Sign in to unlock the full Novartis Ag balance sheet history.

Sign In Create Free Account

About Novartis Ag Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: February 4, 2026
  • Source: nvs-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001114448-26-000004

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License